Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124359153 | 12435915 | 3 | F | 20160708 | 20160604 | 20160715 | EXP | HK-ASTRAZENECA-2016SE57270 | ASTRAZENECA | 63.00 | YR | F | Y | 56.80000 | KG | 20160715 | MD | HK | HK |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124359153 | 12435915 | 1 | PS | TAGRISSO | OSIMERTINIB | 1 | Oral | 1840 | MG | U | 208065 | 80 | MG | TABLET | QD | ||||
124359153 | 12435915 | 2 | SS | IRESSA | GEFITINIB | 1 | Oral | DOSE UNKNOWN | U | U | 0 | TABLET | |||||||
124359153 | 12435915 | 3 | C | HERBAL MEDICINE | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124359153 | 12435915 | 1 | Lung neoplasm malignant |
124359153 | 12435915 | 2 | Skin reaction |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124359153 | 12435915 | DE |
124359153 | 12435915 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124359153 | 12435915 | Acute hepatic failure | |
124359153 | 12435915 | Klebsiella test positive | |
124359153 | 12435915 | Rash | |
124359153 | 12435915 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124359153 | 12435915 | 1 | 20160402 | 20160424 | 0 |